Shopping Cart 0
Cart Subtotal
AED 0

CRELUX GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 0

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 0

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 0

Details

Summary

Crelux GmbH (Crelux), a subsidiary of WuXi AppTec (Shanghai) Co Ltd, is a drug discovery company that discovers drug solutions for pharmacy, biotech and research organizations. The company offers customized and integrated services in areas of drug discovery, X-ray crystallography, protein supply, biophysical analysis and fragment screening. It develops fragment screening platform, which include measurements of enzymatic activities, Kon and off binding kinetics, KD analyses and stability determination of proteins. Crelux's X intract biophysical analytics and screening platform is made of a versatile series of orthogonal assay technologies for hit validation. The company offers services to support small and large molecules in biopharmaceutical products. Crelux is headquartered in Martinsried, Germany.

CRELUX GmbH-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

CRELUX GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

CRELUX GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

CRELUX GmbH, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

AiCuris Enters Into Drug Discovery Agreement With 4SC Discovery And Crelux 10

UCB Enters Into Drug Discovery Agreement With Crelux And 4SC Discovery 12

4SC Enters Into Co-Development Agreement With Crelux And Ribological 13

Acquisition 14

WuXi AppTec Acquires Crelux 14

CRELUX GmbH-Key Competitors 15

CRELUX GmbH-Key Employees 16

CRELUX GmbH-Locations And Subsidiaries 17

Head Office 17

Appendix 18

Methodology 18

About GlobalData 18

Contact Us 18

Disclaimer 18


List Of Figure

List of Figures

CRELUX GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

CRELUX GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

CRELUX GmbH, Pharmaceuticals & Healthcare, Key Facts 2

CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

CRELUX GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

CRELUX GmbH, Deals By Therapy Area, 2012 to YTD 2018 8

CRELUX GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

AiCuris Enters Into Drug Discovery Agreement With 4SC Discovery And Crelux 10

UCB Enters Into Drug Discovery Agreement With Crelux And 4SC Discovery 12

4SC Enters Into Co-Development Agreement With Crelux And Ribological 13

WuXi AppTec Acquires Crelux 14

CRELUX GmbH, Key Competitors 15

CRELUX GmbH, Key Employees 16

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

Summary

Crelux GmbH (Crelux), a subsidiary of WuXi AppTec (Shanghai) Co Ltd, is a drug discovery company that discovers drug solutions for pharmacy, biotech and research organizations. The company offers customized and integrated services in areas of drug discovery, X-ray crystallography, protein supply, biophysical analysis and fragment screening. It develops fragment screening platform, which include measurements of enzymatic activities, Kon and off binding kinetics, KD analyses and stability determination of proteins. Crelux's X intract biophysical analytics and screening platform is made of a versatile series of orthogonal assay technologies for hit validation. The company offers services to support small and large molecules in biopharmaceutical products. Crelux is headquartered in Martinsried, Germany.

CRELUX GmbH-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

CRELUX GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

CRELUX GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

CRELUX GmbH, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

AiCuris Enters Into Drug Discovery Agreement With 4SC Discovery And Crelux 10

UCB Enters Into Drug Discovery Agreement With Crelux And 4SC Discovery 12

4SC Enters Into Co-Development Agreement With Crelux And Ribological 13

Acquisition 14

WuXi AppTec Acquires Crelux 14

CRELUX GmbH-Key Competitors 15

CRELUX GmbH-Key Employees 16

CRELUX GmbH-Locations And Subsidiaries 17

Head Office 17

Appendix 18

Methodology 18

About GlobalData 18

Contact Us 18

Disclaimer 18


List Of Figure

List of Figures

CRELUX GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

CRELUX GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

CRELUX GmbH, Pharmaceuticals & Healthcare, Key Facts 2

CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

CRELUX GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

CRELUX GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

CRELUX GmbH, Deals By Therapy Area, 2012 to YTD 2018 8

CRELUX GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

AiCuris Enters Into Drug Discovery Agreement With 4SC Discovery And Crelux 10

UCB Enters Into Drug Discovery Agreement With Crelux And 4SC Discovery 12

4SC Enters Into Co-Development Agreement With Crelux And Ribological 13

WuXi AppTec Acquires Crelux 14

CRELUX GmbH, Key Competitors 15

CRELUX GmbH, Key Employees 16

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS